The Health Care M&A Monthly: Merck KGaA Buys Millipore–
Snatches Life Sciences Firm From Thermo Fisher Merger Monday, the first day of March, brought us the news that Germany’s Merck KGaA (DE: MRCG) would acquire the American life sciences company Millipore Corp. (NYSE: MIL) for $7.2 billion. While this deal will give MRCG...Health Care Deal News: First Quarter M&A Results–
A Total Of 249 Deals Announced Worth $34.0 Billion The first quarter of 2012 saw a strong merger and acquisition market in the health care industry. Based on preliminary figures, a total of 249 deals were announced in 13 sectors worth a combined total of $34.0...Health Care Deal News: Spotlight on Medical Devices
Being profitable doesn’t make a division all that valuable, it appears. In the wake of its $3.72 billion acquisition of Gen-Probe (NASDAQ: GPRO) last year, Hologic, Inc. (NASDAQ: HOLX) began cleaning house in order to pay its debts. One result: Immucor, Inc. agreed to...The Health Care M&A Monthly: Devices Dominate Dealmaking
Seventeen Transactions Announced Worth $1.4 Billion The health care merger and acquisition market for January 2010 generated a total of 70 deals with a combined value of $5.4 billion. As we have come to expect, the four sectors of the health care technology segment...The Health Care M&A Monthly: Private Equity Bounces Back
Captures 21 Percent Of M&A Dollars In Q4:09 Private equity groups have felt the pain of the Credit Crunch just as keenly as other businesses, if not more so. When they undertook leveraged buyouts in the past, they would often pony up a modest amount of their own...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
